• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Research Brief on (3S)-3,7-diaminoheptanoic acid (CAS: 13184-41-3): Recent Advances and Applications

(3S)-3,7-diaminoheptanoic acid (CAS: 13184-41-3) is a non-proteinogenic amino acid that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a building block for novel peptide-based therapeutics, enzyme inhibitors, and drug delivery systems. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and emerging applications in drug development.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficient synthesis of (3S)-3,7-diaminoheptanoic acid via asymmetric catalytic hydrogenation, achieving high enantiomeric purity (>99% ee). The researchers highlighted its utility as a key intermediate in the synthesis of γ-amino acid derivatives, which show promise as modulators of neurotransmitter receptors. The study also reported improved synthetic yields compared to previous methods, making this compound more accessible for pharmaceutical research.

In the area of antimicrobial research, (3S)-3,7-diaminoheptanoic acid has been incorporated into novel antimicrobial peptides (AMPs) that exhibit potent activity against multidrug-resistant bacterial strains. A recent Nature Communications paper described the design of amphipathic peptides containing this amino acid that disrupt bacterial membranes while showing minimal cytotoxicity to mammalian cells. The unique spacing of amino groups in (3S)-3,7-diaminoheptanoic acid was found to enhance peptide-membrane interactions, suggesting its potential as a scaffold for next-generation antibiotics.

Oncology applications have also emerged for this compound. Research published in Cancer Research revealed that derivatives of (3S)-3,7-diaminoheptanoic acid can selectively inhibit lysine-specific demethylase 1 (LSD1), an epigenetic regulator implicated in various cancers. The study demonstrated that these inhibitors effectively suppressed tumor growth in xenograft models while showing improved pharmacokinetic properties compared to existing LSD1 inhibitors. The compound's structural flexibility allows for optimization of both potency and selectivity against this challenging drug target.

From a drug delivery perspective, (3S)-3,7-diaminoheptanoic acid has been utilized in the development of novel polymeric carriers. A 2024 study in Advanced Materials reported pH-responsive nanoparticles incorporating this amino acid that demonstrated enhanced tumor accumulation and controlled drug release. The dual amino functionality enables precise tuning of polymer properties, including biodegradation rates and drug loading capacity, making it particularly valuable for targeted cancer therapies.

Looking forward, the versatility of (3S)-3,7-diaminoheptanoic acid positions it as a promising candidate for various biomedical applications. Ongoing research is exploring its use in mRNA delivery systems, neurodegenerative disease therapeutics, and as a component of supramolecular biomaterials. The compound's commercial availability (CAS: 13184-41-3) and improved synthetic routes are expected to accelerate its adoption in both academic and industrial research settings. Future studies will likely focus on expanding its therapeutic applications while optimizing its physicochemical properties for specific medical indications.

• 2835-82-7(DL-3-Amino-n-butyric acid)
• 3775-73-3((3R)-3-aminobutanoic acid)
• 541-48-0(rac 3-Aminobutyric Acid)
• 3775-72-2((3S)-3-aminobutanoic acid)
• 22818-43-5((S)-3-Amino-5-methylhexanoic acid)
• 3653-34-7(3-Amino-5-methylhexanoic acid)
• 18664-78-3(3-Amino-pentanoic Acid)
• 14389-77-6((S)-3-Aminopentanoic acid)
• 5427-96-3(3-Aminoadipic acid)
• 1948-48-7(β-Glutamic Acid)